LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Maji, Manideepa"
  2. AU=Evans Heather L
  3. AU="Cheng, Shuai"
  4. AU="Zalis, Joshua"

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Irregular erythrocyte antibodies among antenatal women and their neonatal outcome at a tertiary care hospital in Northern India.

    Mandal, Saikat / Kaur, Daljit / Negi, Gita / Basu, Sriparna / Chaturvedi, Jaya / Maji, Manideepa / Malhotra, Sheetal

    Postgraduate medical journal

    2023  Volume 99, Issue 1169, Page(s) 145–152

    Abstract: Background: Red blood cell alloimmunisation during the pregnancy is a significant cause for neonatal mortality and morbidity. This study was planned to determine the prevalence and specificity of irregular erythrocyte antibodies in antenatal mothers and ...

    Abstract Background: Red blood cell alloimmunisation during the pregnancy is a significant cause for neonatal mortality and morbidity. This study was planned to determine the prevalence and specificity of irregular erythrocyte antibodies in antenatal mothers and their neonatal outcome.
    Methods: In this observational study, blood grouping and red cell antibody screening of mothers were performed at first visit and after 28 weeks of gestation and positive cases were identified and followed up monthly till delivery by repeating antibody titre and middle cerebral artery-peak systolic velocity. After delivery of alloimmunised mothers, cord blood haemoglobin, bilirubin and direct antiglobulin tests (DAT) were analysed and further outcome of neonate was recorded.
    Results: Among 652 registered antenatal cases, 18 multigravida women were found to be alloimmunised, accounting to prevalence of 2.8%. Most common alloantibody identified was anti D (>70%) followed by anti-Lea, anti-C, anti-Leb, anti-E and anti-Jka. Only 47.7% Rh D negative women received anti-D prophylaxis during previous pregnancies or whenever indicated. DAT was positive in 56.2% of neonates. Among nine DAT positive neonates, two early neonatal deaths due to severe anaemia were observed following birth resuscitation. Four antenatal mothers required intrauterine transfusion in view of fetal anaemia while three neonates received double volume exchange transfusion and top up transfusions after birth.
    Conclusions: This study emphasises importance of red cell antibody screening for all multigravida antenatal women at registration of pregnancy and additionally at 28 weeks or later in high-risk cases irrespective of RhD status.
    MeSH term(s) Pregnancy ; Infant, Newborn ; Female ; Humans ; Tertiary Care Centers ; Bilirubin ; Erythrocytes ; India
    Chemical Substances Bilirubin (RFM9X3LJ49)
    Language English
    Publishing date 2023-05-24
    Publishing country England
    Document type Observational Study ; Journal Article
    ZDB-ID 80325-x
    ISSN 1469-0756 ; 0032-5473
    ISSN (online) 1469-0756
    ISSN 0032-5473
    DOI 10.1136/postgradmedj-2021-140497
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Severity of Vitamin D Deficiency in Children with Nephrotic Syndrome: A Study from Tertiary Care Center in Northern India.

    Maji, Manideepa / Kumar, Manish / Chacham, Swathi / Mirza, Anissa Atif / Bhat, Nowneet Kumar / Mandal, Saikat

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

    2023  Volume 33, Issue 5, Page(s) 608–616

    Abstract: In nephrotic syndrome (NS) due to podocytopathies, loss of vitamin D binding globulin along with albumin in urine leads to Vitamin D deficient state. We aimed to study the severity of vitamin D deficiency and its clinical correlation in children with NS. ...

    Abstract In nephrotic syndrome (NS) due to podocytopathies, loss of vitamin D binding globulin along with albumin in urine leads to Vitamin D deficient state. We aimed to study the severity of vitamin D deficiency and its clinical correlation in children with NS. We performed a cross-sectional study at a tertiary care hospital in Northern India. Enrolment of children aged 1-18 years was done. Patient's detailed history, numbers of relapse, treatment details, and data regarding various immunomodulatory drugs treatment. Vitamin D level was estimated, and its status was further classified as deficiency <20 ng/mL and insufficiency 20-30 ng/mL as per Global Consensus Recommendations on evaluation, treatment, and prevention of vitamin D deficiency. Continuous variables were compared using tests such as unpaired t-test, Kruskal-Wallis test, and Wilcoxon rank sum test depending on the distribution of parameters. Categorical variables were compared using Chi-squared tests or Fisher's exact test. A total of 96 children with NS were screened, of which 77.1% had vitamin D deficiency. The mean serum vitamin D level was 14.393 ± 8.52 ng/mL. Among the 48 children of the first episode of NS 36 were deficient (36/48 = 75%). Whereas in the relapse category, 30 patients had infrequently relapsing NS (deficient 24/30 = 80%). Eleven children had frequently relapsing NS; among them, 10 were vitamin D deficient (10/11 = 90.9%), and there was a negative correlation between vitamin D level and duration of illness. Vitamin D deficiency is a common comorbidity in children with NS. Given the putative immunomodulatory property of vitamin D, this deficiency should be identified and treated routinely in all cases of NS.
    MeSH term(s) Humans ; Child ; Tertiary Care Centers ; Nephrotic Syndrome/diagnosis ; Nephrotic Syndrome/drug therapy ; Nephrotic Syndrome/epidemiology ; Cross-Sectional Studies ; Vitamin D Deficiency/diagnosis ; Vitamin D Deficiency/epidemiology ; Vitamin D Deficiency/drug therapy ; Vitamin D/therapeutic use ; India/epidemiology ; Recurrence
    Chemical Substances Vitamin D (1406-16-2)
    Language English
    Publishing date 2023-11-07
    Publishing country Saudi Arabia
    Document type Journal Article
    ZDB-ID 1379955-1
    ISSN 1319-2442
    ISSN 1319-2442
    DOI 10.4103/1319-2442.389421
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Therapeutic Response to Sublingual Methylcobalamin in Children With Vitamin B12 Deficiency Anemia.

    Saxena, Chahat / Kumari, Sweta / Dewan, Pooja / Gomber, Sunil / Agarwal, Rachna / Sharma, Sangeeta / Radhakrishnan, Nita / Maji, Manideepa

    Indian pediatrics

    2023  Volume 60, Issue 11, Page(s) 913–916

    Abstract: Objective: To evaluate the efficacy and safety of sublingual methylcobalamin for the treatment of vitamin B12 deficiency anemia in children.: Methods: A single arm intervention study was conducted between November, 2020 and April, 2022 in children ... ...

    Abstract Objective: To evaluate the efficacy and safety of sublingual methylcobalamin for the treatment of vitamin B12 deficiency anemia in children.
    Methods: A single arm intervention study was conducted between November, 2020 and April, 2022 in children aged 1-12 years with vitamin B12 deficiency anemia. Children aged 1-6 years received a tablet of methylcobalamin (1500 mcg) by sublingual route every alternate day (three doses) while those aged 7-12 years received five such doses. Thereafter, one such sublingual tablet was given weekly and all participants were followed-up for 6 weeks.
    Results: 37 children with a mean (SD) age of 8.2 (4.1) years were treated and followed up prospectively. On day 10, no child needed rescue therapy with parenteral methylcobalamin. After 6 weeks, the mean (SD) serum cobalamin (mL) increased from 123.3 (35.5) pg/mL to 507.3 (274.2) pg/mL (P<0.001), plasma homocysteine (L) decreased from 48.9 (17.8) pg/mL to 16.3 (8.5) µmol/L (P<0.001), the mean (SD) hemoglobin increased by 2.3 (1.1) g/dL (P<0.001), and MCV decreased by 12.9 (6.8) fL (P<0.001). 67.6% children persisted to have anemia, albeit majority of them had mild or moderate anemia. There were no unsolicited side-effect reported.
    Conclusion: Sublingual methylcobalamin is effective for the treatment of vitamin B12 deficiency anemia in children; although, the duration of treatment needs to be longer than six weeks.
    MeSH term(s) Humans ; Child ; Vitamin B 12 Deficiency/drug therapy ; Vitamin B 12/therapeutic use ; Gastrointestinal Diseases ; Anemia ; Tablets/therapeutic use
    Chemical Substances mecobalamin (BR1SN1JS2W) ; Vitamin B 12 (P6YC3EG204) ; Tablets
    Language English
    Publishing date 2023-05-30
    Publishing country India
    Document type Journal Article
    ZDB-ID 402594-5
    ISSN 0974-7559 ; 0019-6061
    ISSN (online) 0974-7559
    ISSN 0019-6061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Irregular erythrocyte antibodies among antenatal women and their neonatal outcome at a tertiary care hospital in Northern India.

    Mandal, Saikat / Kaur, Daljit / Negi, Gita / Basu, Sriparna / Chaturvedi, Jaya / Maji, Manideepa / Malhotra, Sheetal

    Postgraduate medical journal

    2021  

    Abstract: Background: Red blood cell alloimmunisation during the pregnancy is a significant cause for neonatal mortality and morbidity. This study was planned to determine the prevalence and specificity of irregular erythrocyte antibodies in antenatal mothers and ...

    Abstract Background: Red blood cell alloimmunisation during the pregnancy is a significant cause for neonatal mortality and morbidity. This study was planned to determine the prevalence and specificity of irregular erythrocyte antibodies in antenatal mothers and their neonatal outcome.
    Methods: In this observational study, blood grouping and red cell antibody screening of mothers were performed at first visit and after 28 weeks of gestation and positive cases were identified and followed up monthly till delivery by repeating antibody titre and middle cerebral artery-peak systolic velocity. After delivery of alloimmunised mothers, cord blood haemoglobin, bilirubin and direct antiglobulin tests (DAT) were analysed and further outcome of neonate was recorded.
    Results: Among 652 registered antenatal cases, 18 multigravida women were found to be alloimmunised, accounting to prevalence of 2.8%. Most common alloantibody identified was anti D (>70%) followed by anti-Lea, anti-C, anti-Leb, anti-E and anti-Jka. Only 47.7% Rh D negative women received anti-D prophylaxis during previous pregnancies or whenever indicated. DAT was positive in 56.2% of neonates. Among nine DAT positive neonates, two early neonatal deaths due to severe anaemia were observed following birth resuscitation. Four antenatal mothers required intrauterine transfusion in view of fetal anaemia while three neonates received double volume exchange transfusion and top up transfusions after birth.
    Conclusions: This study emphasises importance of red cell antibody screening for all multigravida antenatal women at registration of pregnancy and additionally at 28 weeks or later in high-risk cases irrespective of RhD status.
    Language English
    Publishing date 2021-11-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 80325-x
    ISSN 1469-0756 ; 0032-5473
    ISSN (online) 1469-0756
    ISSN 0032-5473
    DOI 10.1136/postmj/postgradmedj-2021-140497
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: COVID 19 infection associated with thrombotic thrombocytopenic purpura.

    Dhingra, Gaurav / Maji, Manideepa / Mandal, Saikat / Vaniyath, Sudeep / Negi, Gita / Nath, Uttam Kumar

    Journal of thrombosis and thrombolysis

    2021  Volume 52, Issue 2, Page(s) 504–507

    Abstract: Thrombotic thrombocytopenic purpura (TTP) which can cause significant mortality is a thrombotic microangiopathy due to deficiency of VWF cleaving protease ADAMTS13 and as per medical literature there are examples that TTP can be caused by COVID 19 ... ...

    Abstract Thrombotic thrombocytopenic purpura (TTP) which can cause significant mortality is a thrombotic microangiopathy due to deficiency of VWF cleaving protease ADAMTS13 and as per medical literature there are examples that TTP can be caused by COVID 19 infection. A 35 years old female after admission with right sided weakness and slurring of speech was found to be COVID positive and diagnosed as a case of TTP. Patient had absent ADAMTS13 level on day 1. Treatment was started with therapeutic plasma exchange (TPE) later injection Vincristine and Rituximab was given after 4th TPE as it was suspected as refractory case. Finally patient received 16 TPE procedures with cryo poor plasma as exchange fluid and gradually her platelet count started to maintain normal and she was discharged. Specific management and such association of this type of cases need to be studied more judiciously.
    MeSH term(s) ADAMTS13 Protein/blood ; ADAMTS13 Protein/deficiency ; Adult ; Antineoplastic Agents/administration & dosage ; COVID-19/blood ; COVID-19/complications ; COVID-19/diagnosis ; Female ; Humans ; Immunologic Factors/administration & dosage ; Plasma Exchange/methods ; Platelet Count/methods ; Purpura, Thrombotic Thrombocytopenic/blood ; Purpura, Thrombotic Thrombocytopenic/diagnosis ; Purpura, Thrombotic Thrombocytopenic/etiology ; Purpura, Thrombotic Thrombocytopenic/therapy ; Rituximab/administration & dosage ; SARS-CoV-2/isolation & purification ; Treatment Outcome ; Vincristine/administration & dosage
    Chemical Substances Antineoplastic Agents ; Immunologic Factors ; Rituximab (4F4X42SYQ6) ; Vincristine (5J49Q6B70F) ; ADAMTS13 Protein (EC 3.4.24.87) ; ADAMTS13 protein, human (EC 3.4.24.87)
    Language English
    Publishing date 2021-04-27
    Publishing country Netherlands
    Document type Case Reports ; Journal Article
    ZDB-ID 1230645-9
    ISSN 1573-742X ; 0929-5305
    ISSN (online) 1573-742X
    ISSN 0929-5305
    DOI 10.1007/s11239-021-02452-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Visceral Leishmaniasis Associated with Hemophagocytic Lymphohistiocytosis.

    Bolia, Rishi / Singh, Avinish / Maji, Manideepa / Misra, Medha / Sharawat, Indar Kumar / Panda, Prateek Kumar

    Indian journal of pediatrics

    2020  Volume 88, Issue 1, Page(s) 73

    MeSH term(s) Humans ; Leishmaniasis, Visceral/complications ; Leishmaniasis, Visceral/diagnosis ; Lymphohistiocytosis, Hemophagocytic/complications ; Lymphohistiocytosis, Hemophagocytic/diagnosis
    Language English
    Publishing date 2020-06-03
    Publishing country India
    Document type Letter
    ZDB-ID 218231-2
    ISSN 0973-7693 ; 0019-5456
    ISSN (online) 0973-7693
    ISSN 0019-5456
    DOI 10.1007/s12098-020-03361-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top